The platform covers in vivo and in vitro pharmacodynamics, pharmacokinetics, Non-GLP toxicology studies, etc. The team has 200+CDX models, hundreds of PDX models and 50+ autoimmune and inflammatory models, and metabolic disease models. Among them, the pharmacodynamic services such as tumor pharmacological models (syngeneic model, CDX model, PDX model, orthotopic tumor model, tumor metastasis model), autoimmune and inflammatory animal model, humanized model, metabolic disease model and others, are the advantageous technologies.

The team has established a solid research quality system to ensure the authenticity, accuracy, integrity, traceability of test data, and the timeliness of delivery. The team's rich project experience will effectively help the partner's new drug R&D project.

The platform takes research and technological innovation as the guide to ensure the quality of R&D technology, commit to provide customers with high-quality and efficient R&D services, Help enterprises improve the drug research success rate, reduce the cycles and costs of drug R&D, and continuously improve research quality.